Skip to content

Variation of pathogen infection spectrum in liver cirrhosis with esophagogastric variceal bleeding

Variation of pathogen infection spectrum in liver cirrhosis with esophagogastric variceal bleeding

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019953
Enrollment
Unknown
Registered
2018-12-09
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis with esophagogastric variceal bleeding

Interventions

Hospitalized cirrhosis:NA

Sponsors

Infection Disease Center of the Fifth Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) the patient has been clearly diagnosed with cirrhosis or newly diagnosed with cirrhosis; (2) endoscopic examination revealed gastroesophageal varices; (3) willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) definite infection or unknown cause when bleeding with fever; (2) has used antibiotics after bleeding, or has used antibiotics recently (within 3 days); (3) bleeding occurred for more than 3 days; (4) pregnant or lactating women; (5) complicated with liver cancer; (6) combined with biliary tract or gastrointestinal diseases, such as gastric ulcer, pancreatitis, crohn's disease, acute gastroenteritis, biliary tract obstruction, cholecystitis, parasitic infection and other diseases that may affect intestinal flora; (7) other conditions considered inappropriate by the researchers for inclusion.

Design outcomes

Primary

MeasureTime frame
endotoxin;

Countries

China

Contacts

Public ContactXia Jinyu

Infection Disease Center of the Fifth Affiliated Hospital of Sun Yat-sen University

xiajinyu@mail.sysu.edu.cn+86 13823078064

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026